HomeCompareSCID vs JNJ

SCID vs JNJ: Dividend Comparison 2026

SCID yields 8.13% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SCID wins by $14.2K in total portfolio value
10 years
SCID
SCID
● Live price
8.13%
Share price
$24.62
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$1,358.45
Full SCID calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — SCID vs JNJ

📍 SCID pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSCIDJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SCID + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SCID pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SCID
Annual income on $10K today (after 15% tax)
$690.64/yr
After 10yr DRIP, annual income (after tax)
$1,154.68/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, SCID beats the other by $451.07/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SCID + JNJ for your $10,000?

SCID: 50%JNJ: 50%
100% JNJ50/50100% SCID
Portfolio after 10yr
$27.1K
Annual income
$1,093.11/yr
Blended yield
4.03%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

SCID
No analyst data
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SCID buys
0
JNJ buys
0
No recent congressional trades found for SCID or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSCIDJNJ
Forward yield8.13%3.36%
Annual dividend / share$2.00$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$34.2K$20.0K
Annual income after 10y$1,358.45$827.78
Total dividends collected$10.9K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: SCID vs JNJ ($10,000, DRIP)

YearSCID PortfolioSCID Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,513$812.51$10,676$355.77+$837.00SCID
2$13,193$874.21$11,407$389.39+$1.8KSCID
3$15,052$936.25$12,198$426.53+$2.9KSCID
4$17,104$998.35$13,056$467.62+$4.0KSCID
5$19,362$1,060.23$13,987$513.12+$5.4KSCID
6$21,839$1,121.65$14,998$563.56+$6.8KSCID
7$24,550$1,182.38$16,098$619.52+$8.5KSCID
8$27,511$1,242.21$17,295$681.69+$10.2KSCID
9$30,737$1,300.95$18,599$750.82+$12.1KSCID
10$34,247$1,358.45$20,022$827.78+$14.2KSCID

SCID vs JNJ: Complete Analysis 2026

SCIDStock

The investment seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Scientific Beta Extended Developed Europe Multi-Beta Multi-Strategy Four-Factor Equal Risk Contribution (ERC) Index. The fund invests at least 80% of its total assets in the securities of the underlying index and in American Depositary Receipts ("ADRs") and Global Depositary Receipts based on the securities in the underlying index. The underlying index generally comprises approximately 600 or less European-listed common stocks selected based on a proprietary methodology developed by the index provider.

Full SCID Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this SCID vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SCID vs SCHDSCID vs JEPISCID vs OSCID vs KOSCID vs MAINSCID vs ABBVSCID vs MRKSCID vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.